Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
CareStream

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 22 November 2002:
Vol. 298. no. 5598, pp. 1531 - 1533
DOI: 10.1126/science.298.5598.1531b
Prev | Table of Contents | Next

News of the Week

RESEARCH MISCONDUCT:
German Inquiry Finds Flaws, Not Fraud

Adam Bostanci and Gretchen Vogel

BERLIN--A paper claiming a spectacular remission of tumors from the use of an experimental cancer vaccine is marred by shoddy scientific practices, but investigators aren't saying whether the results are also too good to be true. Last week the University of Göttingen said that its investigative committee had found evidence of sloppiness that constitutes misconduct, but not fraud, in the disputed paper. But with only a brief statement to go on, scientists following up on the work still don't know whether the data are valid.

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)